Literature DB >> 10669453

Tuberculosis in prisons in countries with high prevalence.

R Coninx1, D Maher, H Reyes, M Grzemska.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10669453      PMCID： PMC1117551          DOI： 10.1136/bmj.320.7232.440

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

Review 1.  Pitfalls of tuberculosis programmes in prisons.

Authors:  H Reyes; R Coninx
Journal:  BMJ       Date:  1997-11-29

2.  Impact of tuberculosis control measures and crowding on the incidence of tuberculous infection in Maryland prisons.

Authors:  C R MacIntyre; N Kendig; L Kummer; S Birago; N M Graham
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

3.  Tuberculosis in Russia.

Authors:  D F Wares; C I Clowes
Journal:  Lancet       Date:  1997-09-27       Impact factor: 79.321

4.  Tuberculosis in prisons--forgotten plague.

Authors:  F Drobniewski
Journal:  Lancet       Date:  1995-10-07       Impact factor: 79.321

5.  Tuberculosis in prisons.

Authors:  R Coninx; B Eshaya-Chauvin; H Reyes
Journal:  Lancet       Date:  1995-11-04       Impact factor: 79.321

6.  Tuberculosis in a prison population in Malawi.

Authors:  D S Nyangulu; A D Harries; C Kang'ombe; A E Yadidi; K Chokani; T Cullinan; D Maher; P Nunn; F M Salaniponi
Journal:  Lancet       Date:  1997-11-01       Impact factor: 79.321

7.  Smear positive pulmonary tuberculosis in a prison setting: experience in the penal camp of Bouaké, Ivory Coast.

Authors:  N Koffi; A K Ngom; E Aka-Danguy; A Séka; A Akoto; D Fadiga
Journal:  Int J Tuberc Lung Dis       Date:  1997-06       Impact factor: 2.373

8.  Association of tuberculosis infection with increased time in or admission to the New York City jail system.

Authors:  E Y Bellin; D D Fletcher; S M Safyer
Journal:  JAMA       Date:  1993-05-05       Impact factor: 56.272

9.  Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

Authors:  A Pablos-Méndez; M C Raviglione; A Laszlo; N Binkin; H L Rieder; F Bustreo; D L Cohn; C S Lambregts-van Weezenbeek; S J Kim; P Chaulet; P Nunn
Journal:  N Engl J Med       Date:  1998-06-04       Impact factor: 91.245

10.  [Tuberculosis in the prison milieu at Antananarivo from 1990 to 1993].

Authors:  G Auregan; F Rakotomanana; M Ratsitorahina; N Rakotoniaina; O Rabemananjara; R Raharimanana; P Boisier
Journal:  Arch Inst Pasteur Madagascar       Date:  1995
  10 in total
  22 in total

1.  Prisons as social determinants of hepatitis C virus and tuberculosis infections.

Authors:  Niyi Awofeso
Journal:  Public Health Rep       Date:  2010 Jul-Aug       Impact factor: 2.792

2.  Mass incarceration can explain population increases in TB and multidrug-resistant TB in European and central Asian countries.

Authors:  David Stuckler; Sanjay Basu; Martin McKee; Lawrence King
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-26       Impact factor: 11.205

Review 3.  Transforming the fight against tuberculosis: targeting catalysts of transmission.

Authors:  David W Dowdy; Andrew S Azman; Emily A Kendall; Barun Mathema
Journal:  Clin Infect Dis       Date:  2014-06-30       Impact factor: 9.079

4.  Understanding the "Russian mortality paradox" in Central Asia: evidence from Kyrgyzstan.

Authors:  Michel Guillot; Natalia Gavrilova; Tetyana Pudrovska
Journal:  Demography       Date:  2011-08

5.  Tuberculosis incidence and treatment completion among Ugandan prison inmates.

Authors:  A Schwitters; M Kaggwa; P Omiel; G Nagadya; N Kisa; S Dalal
Journal:  Int J Tuberc Lung Dis       Date:  2014-07       Impact factor: 2.373

6.  Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia.

Authors:  M Ruddy; Y Balabanova; C Graham; I Fedorin; N Malomanova; E Elisarova; S Kuznetznov; G Gusarova; S Zakharova; A Melentyev; E Krukova; V Golishevskaya; V Erokhin; I Dorozhkova; F Drobniewski
Journal:  Thorax       Date:  2005-02       Impact factor: 9.139

7.  Influences of cross-border mobility on tuberculosis diagnoses and treatment interruption among injection drug users in Tijuana, Mexico.

Authors:  Robert Deiss; Richard S Garfein; Remedios Lozada; Jose Luis Burgos; Kimberly C Brouwer; Kathleen S Moser; Maria Luisa Zuniga; Timothy C Rodwell; Victoria D Ojeda; Steffanie A Strathdee
Journal:  Am J Public Health       Date:  2009-06-18       Impact factor: 9.308

Review 8.  Co-infection with human immunodeficiency virus and tuberculosis in Asia.

Authors:  Sten H Vermund; Naoki Yamamoto
Journal:  Tuberculosis (Edinb)       Date:  2007-07-16       Impact factor: 3.131

9.  Screening and rapid molecular diagnosis of tuberculosis in prisons in Russia and Eastern Europe: a cost-effectiveness analysis.

Authors:  Daniel E Winetsky; Diana M Negoescu; Emilia H DeMarchis; Olga Almukhamedova; Aizhan Dooronbekova; Dilshod Pulatov; Natalia Vezhnina; Douglas K Owens; Jeremy D Goldhaber-Fiebert
Journal:  PLoS Med       Date:  2012-11-27       Impact factor: 11.069

Review 10.  State of affairs of tuberculosis in prison facilities: a systematic review of screening practices and recommendations for best TB control.

Authors:  Natalie V S Vinkeles Melchers; Sabine L van Elsland; Joep M A Lange; Martien W Borgdorff; Jan van den Hombergh
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.